VECTURA GROUP PLC
Summary
Vectura Group develops inhaled therapies for the treatment of respiratory diseases. The company's main products are used to treat asthma and chronic obstructive pulmonary disease.
Deals Overview
Total Deals4
Valued Deals3
Total Value£ 1.58 B
Avg. Deal Size£ 527 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
